His primary scientific interests are in Oncostatin M, Matrix metalloproteinase, Chondrocyte, Immunology and Biochemistry. His Oncostatin M study typically links adjacent topics like Molecular biology. Andrew D. Rowan combines subjects such as Signal transduction, Collagenase and Pathology with his study of Matrix metalloproteinase.
His work in Pathology covers topics such as Tumor necrosis factor alpha which are related to areas like In vivo. His research in the fields of Affinity chromatography, Cysteine, Bromelain and Collagen, type I, alpha 1 overlaps with other disciplines such as Stem bromelain. His Cytokine research includes elements of Proinflammatory cytokine and Cell biology.
The scientist’s investigation covers issues in Cell biology, Matrix metalloproteinase, Oncostatin M, Immunology and Collagenase. His Cell biology study combines topics from a wide range of disciplines, such as Chondrocyte, Internal medicine and Gene expression. His Matrix metalloproteinase research incorporates themes from Arthritis, Cancer research and Pathology.
His Oncostatin M study deals with Molecular biology intersecting with In vivo. The Immunology study combines topics in areas such as Signal transduction and Gerontology. His work carried out in the field of Collagenase brings together such families of science as Hydroxyproline, Tissue inhibitor of metalloproteinase and Collagen, type I, alpha 1.
His main research concerns Cell biology, Matrix metalloproteinase, Cancer research, Extracellular matrix and Pathology. His Cell biology research incorporates elements of Chondrocyte, Collagenase, Immunology and Type II collagen. In his research, Oncostatin M is intimately related to p38 mitogen-activated protein kinases, which falls under the overarching field of Collagenase.
Andrew D. Rowan focuses mostly in the field of Immunology, narrowing it down to matters related to Signal transduction and, in some cases, Inflammation and Arthritis. His study in Matrix metalloproteinase is interdisciplinary in nature, drawing from both Extracellular and MAPK/ERK pathway. The various areas that Andrew D. Rowan examines in his Pathology study include Intratumor heterogeneity and Gerontology.
Andrew D. Rowan mainly investigates Cell biology, Chondrocyte, Immunology, Pathology and Oncostatin M. Andrew D. Rowan is involved in the study of Cell biology that focuses on Extracellular matrix in particular. His biological study spans a wide range of topics, including Proteasome inhibitor, Ubiquitin and Transgene.
The study incorporates disciplines such as Inflammation and Receptor in addition to Pathology. His Oncostatin M research is multidisciplinary, incorporating elements of Molecular biology, Signal transduction, GSK-3 and Collagenase. His Molecular biology study integrates concerns from other disciplines, such as Gene silencing and Gene expression.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The Comparative Role of Activator Protein 1 and Smad Factors in the Regulation of Timp-1 and MMP-1 Gene Expression by Transforming Growth Factor-β1 *
Marie-Claire Hall;David A. Young;Jasmine G. Waters;Andrew D. Rowan.
Journal of Biological Chemistry (2003)
The modulation of matrix metalloproteinase and ADAM gene expression in human chondrocytes by interleukin‐1 and oncostatin M: A time‐course study using real‐time quantitative reverse transcription–polymerase chain reaction
P. J. T. Koshy;C. J. Lundy;A. D. Rowan;S. Porter.
Arthritis & Rheumatism (2002)
The cysteine proteinases of the pineapple plant.
A D Rowan;D J Buttle;A J Barrett.
Biochemical Journal (1990)
Interleukin 17 induces cartilage collagen breakdown: novel synergistic effects in combination with proinflammatory cytokines
P J Koshy;N Henderson;C Logan;P F Life.
Annals of the Rheumatic Diseases (2002)
The role of oncostatin M in animal and human connective tissue collagen turnover and its localization within the rheumatoid joint
T. E. Cawston;V. A. Curry;C. A. Summers;I. M. Clark.
Arthritis & Rheumatism (1998)
Leptin produced by joint white adipose tissue induces cartilage degradation via upregulation and activation of matrix metalloproteinases
Wang Hui;Gary J Litherland;Martina S Elias;Gareth I Kitson.
Annals of the Rheumatic Diseases (2012)
Synergistic effects of glycoprotein 130 binding cytokines in combination with interleukin-1 on cartilage collagen breakdown.
A. D. Rowan;P. J. T. Koshy;W. D. Shingleton;B. A. Degnan.
Arthritis & Rheumatism (2001)
The mammalian chitinase-like lectin, YKL-40, binds specifically to type I collagen and modulates the rate of type I collagen fibril formation.
Heather F. Bigg;Robin Wait;Andrew D. Rowan;Tim E. Cawston.
Journal of Biological Chemistry (2006)
Stem bromelain: amino acid sequence and implications for weak binding of cystatin.
Anka Ritonja;Andrew D. Rowan;David J. Buttle;Neil D. Rawlings.
FEBS Letters (1989)
Germline APC variants in patients with multiple colorectal adenomas, with evidence for the particular importance of E1317Q
H Lamlum;N Al Tassan;E Jaeger;I Frayling.
Human Molecular Genetics (2000)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: